Literature DB >> 20498217

Increased prevalence of diastolic dysfunction in rheumatoid arthritis.

Kimberly P Liang1, Elena Myasoedova, Cynthia S Crowson, John M Davis, Véronique L Roger, Barry L Karon, Daniel D Borgeson, Terry M Therneau, Richard J Rodeheffer, Sherine E Gabriel.   

Abstract

OBJECTIVE: To compare the prevalence of left ventricular (LV) diastolic dysfunction in subjects with and without rheumatoid arthritis (RA), among those with no history of heart failure (HF), and to determine risk factors for diastolic dysfunction in RA.
METHODS: A cross-sectional, community-based study comparing cohorts of adults with and without RA and without a history of HF was carried out. Standard two-dimensional/Doppler echocardiography was performed in all participants. Diastolic dysfunction was defined as impaired relaxation (with or without increased filling pressures) or advanced reduction in compliance or reversible or fixed restrictive filling.
RESULTS: The study included 244 subjects with RA and 1448 non-RA subjects. Mean age was 60.5 years in the RA cohort (71% female) and 64.9 years (50% female) in the non-RA cohort. The vast majority (>98%) of both cohorts had preserved ejection fraction (EF> or =50%). Diastolic dysfunction was more common in subjects with RA at 31% compared with 26% (age and sex adjusted) in non-RA subjects (OR=1.6; 95% CI 1.2 to 2.4). Patients with RA had significantly lower LV mass, higher pulmonary arterial pressure and higher left atrial volume index than non-RA subjects. RA duration and interleukin 6 (IL-6) level were independently associated with diastolic dysfunction in RA even after adjustment for cardiovascular risk factors.
CONCLUSION: Subjects with RA have a higher prevalence of diastolic dysfunction than those without RA. RA duration and IL-6 are independently associated with diastolic dysfunction, suggesting the impact of chronic autoimmune inflammation on myocardial function in RA. Clinical implications of these findings require further investigation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20498217      PMCID: PMC2920362          DOI: 10.1136/ard.2009.124362

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  31 in total

1.  Diastolic function abnormalities in rheumatoid arthritis. Evaluation By echo Doppler transmitral flow and pulmonary venous flow: relation with duration of disease.

Authors:  M Di Franco; M Paradiso; A Mammarella; V Paoletti; G Labbadia; L Coppotelli; E Taccari; A Musca
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

2.  Diastolic dysfunction in rheumatoid arthritis and duration of disease.

Authors:  Irfan Yavasoglu; Taskin Senturk; Alper Onbasili
Journal:  Rheumatol Int       Date:  2008-05-22       Impact factor: 2.631

3.  Raised pulmonary artery pressures measured with Doppler echocardiography in rheumatoid arthritis patients.

Authors:  J K Dawson; N G Goodson; D R Graham; M P Lynch
Journal:  Rheumatology (Oxford)       Date:  2000-12       Impact factor: 7.580

4.  Diastolic heart function in RA patients.

Authors:  M Wislowska; B Jaszczyk; M Kochmański; S Sypuła; M Sztechman
Journal:  Rheumatol Int       Date:  2007-10-24       Impact factor: 2.631

5.  Myocardial dysfunction in rheumatoid arthritis: a controlled tissue-Doppler echocardiography study.

Authors:  Christophe Meune; Karim Wahbi; Noémie Assous; Simon Weber; André Kahan; Yannick Allanore
Journal:  J Rheumatol       Date:  2007-09-01       Impact factor: 4.666

6.  Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic.

Authors:  Margaret M Redfield; Steven J Jacobsen; John C Burnett; Douglas W Mahoney; Kent R Bailey; Richard J Rodeheffer
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

7.  Echocardiographic evaluation of cardiac diastolic function in patients with rheumatoid arthritis: 5 years of follow-up.

Authors:  Dilek Yazici; Sena Tokay; Sibel Aydin; Ahmet Toprak; Nevsun Inanc; Saidur Rahman Khan; Ali Serdar Fak; Haner Direskeneli
Journal:  Clin Rheumatol       Date:  2008-01-15       Impact factor: 2.980

8.  Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction.

Authors:  Rebecca L Rudominer; Mary J Roman; Richard B Devereux; Stephen A Paget; Joseph E Schwartz; Michael D Lockshin; Mary K Crow; Lisa Sammaritano; Daniel M Levine; Jane E Salmon
Journal:  Arthritis Rheum       Date:  2009-01

9.  The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population.

Authors:  John M Davis; Véronique L Roger; Cynthia S Crowson; Hilal Maradit Kremers; Terry M Therneau; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2008-09

10.  Serum levels of interleukin-6, interleukin-10 and C-reactive protein in relation to left ventricular function in patients with myocardial infarction treated with primary angioplasty.

Authors:  Lukasz Karpiński; Rafał Płaksej; Wojciech Kosmala; Maria Witkowska
Journal:  Kardiol Pol       Date:  2008-12       Impact factor: 3.108

View more
  36 in total

1.  Preventing Heart Failure in Inflammatory and Immune Disorders.

Authors:  Maya Serhal; Chris T Longenecker
Journal:  Curr Cardiovasc Risk Rep       Date:  2014-06

2.  Effects of simvastatin on the function of dendritic cells in patients with rheumatic arthritis.

Authors:  Yuhong Liu; Shasha Wang; Lingxun Shen; Yulan Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-12-22

Review 3.  Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure.

Authors:  Kerry Wright; Cynthia S Crowson; Sherine E Gabriel
Journal:  Heart Fail Clin       Date:  2014-01-10       Impact factor: 3.179

4.  Diastolic dysfunction in rheumatoid arthritis patients with low disease activity.

Authors:  Bożena Targońska-Stępniak; Małgorzata Biskup; Wojciech Biskup; Maria Majdan
Journal:  Clin Rheumatol       Date:  2018-12-12       Impact factor: 2.980

5.  Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease.

Authors:  Cynthia S Crowson; Elena Myasoedova; John M Davis; Veronique L Roger; Barry L Karon; Daniel Borgeson; Richard J Rodeheffer; Terry M Therneau; Sherine E Gabriel
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-05       Impact factor: 4.794

6.  Five-year changes in cardiac structure and function in patients with rheumatoid arthritis compared with the general population.

Authors:  John M Davis; Grace Lin; Jae K Oh; Cynthia S Crowson; Sara J Achenbach; Terry M Therneau; Eric L Matteson; Richard J Rodeheffer; Sherine E Gabriel
Journal:  Int J Cardiol       Date:  2017-03-31       Impact factor: 4.164

Review 7.  Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis.

Authors:  Anne Grete Semb; Eirik Ikdahl; Grunde Wibetoe; Cynthia Crowson; Silvia Rollefstad
Journal:  Nat Rev Rheumatol       Date:  2020-06-03       Impact factor: 20.543

8.  Early Wave Reflection and Pulse Wave Velocity Are Associated with Diastolic Dysfunction in Rheumatoid Arthritis.

Authors:  Lebogang Mokotedi; Sulé Gunter; Chanel Robinson; Frederic Michel; Ahmed Solomon; Gavin R Norton; Angela J Woodiwiss; Linda Tsang; Patrick H Dessein; Aletta M E Millen
Journal:  J Cardiovasc Transl Res       Date:  2019-05-22       Impact factor: 4.132

Review 9.  Novel risk factors for cardiovascular disease in rheumatoid arthritis.

Authors:  Jenny Amaya-Amaya; Juan Camilo Sarmiento-Monroy; Ruben-Dario Mantilla; Ricardo Pineda-Tamayo; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

Review 10.  Cardiac Impairment in Rheumatoid Arthritis and Influence of Anti-TNFα Treatment.

Authors:  Ivica Lazúrová; Ľubomír Tomáš
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.